We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders

By LabMedica International staff writers
Posted on 13 Jan 2022
Print article
Illustration
Illustration

The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.

These are the latest findings of Transparency Market Research (Albany NY, USA), a market intelligence provider.

Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.

There has been rise in the incidence and prevalence of blood disorders such as hemophilia over the last few years. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools, which in turn, is likely to propel the growth of the global coagulometers market. Moreover, the rising consumption of anti-coagulant drugs such as aspirin and heparin that necessitates the use of coagulometers to monitor the treatment progress in those patients is also fueling market growth. However, the high cost of these devices is diverting potential users towards manual coagulation testing, which is expected to restrain the growth of the global coagulometers market.

Based on technology, the global coagulometers market is dominated by the photo-optical detection and electrochemical detection segments which hold the highest market share as most automated coagulometers work on the principle of photo-optical or electrochemical detection. Based on channel type, the multichannel coagulometers segment holds the largest share in the global coagulometers market as multichannel coagulometers are widely used in diagnostic laboratories and hospitals. Based on end-user, the hospitals & diagnostic laboratories segment is expected to account for a major share of the global coagulometers market.

Geographically, North America is expected to hold a major share of the global coagulometers market, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global coagulometers market due to the high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market for coagulometers in the region.

Related Links:
Transparency Market Research 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.